Is Ch 14.18UTC Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Ch 14.18UTC? Is Ch 14.18UTC safe for nursing mother and child? Does Ch 14.18UTC extracts into breast milk? Does Ch 14.18UTC has any long term or short term side effects on infants? Can Ch 14.18UTC influence milk supply or can Ch 14.18UTC decrease milk supply in lactating mothers?
Answer by DrLact: About Ch 14.18UTC usage in lactation
No information is available on the clinical use of Ch 14.18UTC during breastfeeding. Because Ch 14.18UTC is a large protein molecule with a molecular weight of about 150,000, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, Ch 14.18UTC should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be discontinued during Ch 14.18UTC therapy.
Alternate Drugs
Tocilizumab(Low Risk)
Adalimumab(Safe)
Daclizumab(Low Risk)
Alemtuzumab(Low Risk)
Thioguanine(Dangerous)
Cisplatin(Unsafe)
Trastuzumab(Unsafe)
Busulfan(Dangerous)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Docetaxel(Dangerous)
Azelaic Acid(Safe)
Ipilimumab(Unsafe)
Cetuximab(Unsafe)
Vincristine(Dangerous)
Cladribine(Dangerous)
Letrozole(Dangerous)
Carboplatin(Dangerous)
Erlotinib(Unsafe)
Tamoxifen(Dangerous)
Exemestane(Dangerous)
Paclitaxel(Dangerous)
Dactinomycin(Dangerous)
Nivolumab(Unsafe)
Mitoxantrone(Dangerous)
Fluorouracil(Dangerous)
Vinblastine(Dangerous)
Mercaptopurine(Safe)
Bleomycin(Dangerous)
Alemtuzumab(Low Risk)
Vinorelbine(Dangerous)
Hydroxyurea(Low Risk)
Rituximab(Low Risk)
Dacarbazine(Dangerous)
Etoposide(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Doxorubicin(Dangerous)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Cyclophosphamide(Dangerous)